-
公开(公告)号:US20150086698A1
公开(公告)日:2015-03-26
申请号:US14552012
申请日:2014-11-24
发明人: Susumu Miura , Kenji Kojima , Taku Nakano , Ken Kato , Akira Tomizawa , Toshimitsu Yoshioka
CPC分类号: A23C9/1422 , A23C19/0455 , A23C21/00 , A23C2210/20 , A23C2240/05 , A23L33/115 , A23L33/40 , A61K35/20
摘要: Manufacture a powder with high milk-derived complex lipid content that contains milk-derived phospholipids and milk-derived ganglioside at high concentrations, which contains protein by 15 to 35 percent by dry weight and fat by 45 to 60 percent by dry weight, wherein the content of milk-derived complex lipids is 20 percent by dry weight or more, and which can be utilized as a material for functional food, mother's milk substitute or drug, by means of adjusting the pH value of a butter serum or butter serum powder reconstituted liquid to a range of 4.0 to 5.0, adding calcium chloride to promote coagulation of protein, removing the produced sediments, filtering the supernatant by means of ultrafiltration or microfiltration, and then drying the obtained concentrate.
摘要翻译: 以高浓度制造含有乳源性磷脂和乳源神经节苷脂的高乳衍生复合脂质含量的粉末,其含有15〜35%的干重和45〜60%的干重的蛋白质,其中, 乳源性复合脂质的含量为干重的20%以上,可以通过调整黄油血清或黄油血清粉末的pH值而重新配制,可用作功能性食品,母乳替代物或药物的材料。 液体至4.0〜5.0的范围,加入氯化钙促进蛋白质凝结,除去生成的沉淀物,通过超滤或微滤过滤上清液,然后干燥得到的浓缩物。
-
公开(公告)号:US09186366B2
公开(公告)日:2015-11-17
申请号:US13862718
申请日:2013-04-15
发明人: Ken Kato , Susumu Miura , Leo Tanaka , Hiroshi Ueno , Noriko Ueda , Yuko Haruta , Toshimitsu Yoshioka
IPC分类号: A61K31/688 , A23K1/16 , A23K1/18 , A23L1/30 , A23L2/52 , A61K8/68 , A61Q7/00 , A61Q19/02 , C07F9/10
CPC分类号: A61K31/688 , A23K20/158 , A23K50/40 , A23K50/48 , A23L2/52 , A23L33/10 , A23L33/12 , A23V2002/00 , A61K8/68 , A61Q7/00 , A61Q19/02 , C07F9/10 , A23V2250/21 , A23V2200/304 , A23V2200/32
摘要: It is intended to find novel pharmaceutical use of sphingomyelin and to provide preventive or therapeutic agents for various diseases as well as a food and drink product and feed comprising any of these agents. The present invention provides a pharmaceutical agent which contains sphingomyelin as an active ingredient and is any of the following agents: 1) a sialomucin secretion promoter, 2) an agent for preventing drunken sickness (hangover), 3) an antiallergic agent, 4) an antioxidant, 5) an agent for defending against infection, 6) a hair growth agent, 7) a therapeutic agent for demyelinating disease, 8) an anti-pigmentation agent, 9) an anti-inflammatory agent, and 10) an agent for improving learning ability. The present invention also provides a food and drink product or feed, characterized by comprising the agent. It is preferred that the sphingomyelin should be derived from milk.
摘要翻译: 旨在找到鞘磷脂的新药用途,并提供各种疾病的预防或治疗剂,以及包含任何这些药剂的食品和饮料产品和饲料。 本发明提供含有鞘磷脂作为活性成分的药剂,其为以下药剂:1)唾液酸粘蛋白分泌促进剂,2)防酒醉药(宿醉)3,抗过敏剂4) 抗氧化剂,5)防止感染的药剂,6)毛发生长剂,7)脱髓鞘疾病的治疗剂,8)抗色素沉着剂,9)抗炎剂,和10)改善剂 学习能力 本发明还提供一种食品和饮料产品或饲料,其特征在于包含该试剂。 鞘磷脂优选来源于牛奶。
-
公开(公告)号:US08486916B2
公开(公告)日:2013-07-16
申请号:US13676430
申请日:2012-11-14
发明人: Ken Kato , Susumu Miura , Leo Tanaka , Hiroshi Ueno , Noriko Ueda , Yuko Haruta , Toshimitsu Yoshioka
IPC分类号: A61K31/685 , A23J7/00
CPC分类号: A61K31/688 , A23K20/158 , A23K50/40 , A23K50/48 , A23L2/52 , A23L33/10 , A23L33/12 , A23V2002/00 , A61K8/68 , A61Q7/00 , A61Q19/02 , C07F9/10 , A23V2250/21 , A23V2200/304 , A23V2200/32
摘要: It is intended to find novel pharmaceutical use of sphingomyelin and to provide preventive or therapeutic agents for various diseases as well as a food and drink product and feed comprising any of these agents. The present invention provides a pharmaceutical agent which contains sphingomyelin as an active ingredient and is any of the following agents: 1) a sialomucin secretion promoter, 2) an agent for preventing drunken sickness (hangover), 3) an antiallergic agent, 4) an antioxidant, 5) an agent for defending against infection, 6) a hair growth agent, 7) a therapeutic agent for demyelinating disease, 8) an anti-pigmentation agent, 9) an anti-inflammatory agent, and 10) an agent for improving learning ability. The present invention also provides a food and drink product or feed, characterized by comprising the agent. It is preferred that the sphingomyelin should be derived from milk.
-
-